Skip to main content
. Author manuscript; available in PMC: 2020 Jun 2.
Published in final edited form as: Clin Cancer Res. 2017 Jul 1;23(13):e98–e106. doi: 10.1158/1078-0432.CCR-17-0652

Table 3.

Recommended surveillance for individuals with NB predisposition

Age Surveillance studies Frequency
0–6 yr. Abdominal US, Urine VMA and HVA, CXR Every 3 mo.
6–10 yr. Abdominal US, Urine VMA and HVA, CXR Every 6 mo.
>10 yr. No screening recommended

Abbreviations: CXR, chest radiograph [postanterior (PA) and lateral]; mo., months; yr., years.